English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 15 January 2025, 19:32 HKT/SGT
Share:
Li Ning Becomes Official Sportswear Partner for the Chinese Olympic Committee and Delegation from 2025 to 2028

HONG KONG, Jan 15, 2025 - (ACN Newswire) – The Shanghai United Assets and Equity Exchange announced that Li Ning Company Limited (“Li Ning” or the "Company") has been awarded the rights to serve as the official sportswear partner for China's Olympic delegation. Li Ning will provide sportswear for both the Chinese Olympic Committee and the Chinese Sports Delegation from 2025 to 2028.

Li Ning has been a long-term supporter of sports development in China. From 1992 to 2004, the brand proudly served as the official sportswear partner for four consecutive Olympic Games, supporting China’s athletes on the global stage. For more than three decades, Li Ning has also consistently supported various Chinese national sports teams competing internationally.

Mr. Li Ning, Founder and Chairman of Li Ning, stated,A “We are truly honoured to once again partner with the Chinese Olympic Committee and the Chinese Sports Delegation after so many years. This partnership reflects the trust and confidence given to us by the General Administration of Sport of China and the Chinese Olympic Committee. We remain committed to our core value of 'serving the public with sportsmanship' while promoting both the spirit of sports and the Olympic spirit. Our goal is to support the development of China's sports industry and inspire more individuals to adopt an active lifestyle, experience the joy of sports, and share in the pride of China's Olympic aspirations through our products and experiences."

Looking ahead, Li Ning is committed to delivering exceptional sportswear and efficient support to the Chinese Sports Delegation and athletes pursuing their dreams in leading international sporting competitions. Li Ning firmly believes that "Anything is Possible"!



Topic: Press release summary Sectors: Fashion & Apparel, Sports
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Vantage Goldfields Corrects Misleading Announcement by Lions Bay Capital Inc. (LBI)  
Mar 28, 2026 06:26 HKT/SGT
Shoucheng Holdings (0697.HK) Proposes HK$780 Million Dividend: HK$6 Billion in Cumulative Payouts Over Eight Years Solidifies Long-Term Value Logic  
Mar 27, 2026 23:00 HKT/SGT
Everest Medicines Enters into Asset Purchase Agreement for Etripamil Nasal Spray, Expanding Cardiovascular Footprint  
Mar 27, 2026 19:40 HKT/SGT
Xunce Technology's Revenue Surges 449% Half-on-Half: Is a Structural Revaluation to a Hundred-Billion Market Cap Camp on the Horizon?  
Mar 27, 2026 19:19 HKT/SGT
Application Submitted for LENVIMA(R) (lenvatinib) in Japan Seeking Approval of Additional Dosage and Administration for Combination with WELIREG(R) (belzutifan) for Renal Cell Carcinoma that has Progressed After Chemotherapy  
Friday, March 27, 2026 7:14:00 PM
Hitachi and MUFG Bank expand NextGen model to finance vehicles and charging infrastructure for decarbonized mobility  
Friday, March 27, 2026 6:44:00 PM
Analogue 2025 Annual Results Profit Attributable to Owners of the Company Increases 23.5% to HK$167.0 Million  
Mar 27, 2026 18:38 HKT/SGT
Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency  
Friday, March 27, 2026 5:19:00 PM
New "L00 Series" Train for the Seibu Railway's Yamaguchi Line Begins Commercial Operation  
Friday, March 27, 2026 3:51:00 PM
Modern Dental Group Announces 2025 Annual Results, Net Profit Surges 47.7% on Digitalization-Driven Operational Efficiency Gains  
Mar 27, 2026 15:43 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575